ArticleJournal of pharmaceutical policy and practice2025
Cost-utility and budget impact analyses of valganciclovir for cytomegalovirus retinitis in patients with human immunodeficiency virus in Thailand.
Tippawan Wongwian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.